Hemodialysis and Peritoneal Dialysis Market Size & Growth Forecast 2027–2036, By Segments (Type, End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Hemodialysis and Peritoneal Dialysis Market size was valued at USD 129.8 billion in 2026 and is anticipated to grow at a 9.31% CAGR from 2027 to 2036, exceeding USD 316.14 billion by 2036. The industry revenue for 2027 is assessed at USD 139.98 billion.
Get more details on this report
Request Free Sample ReportHemodialysis and Peritoneal Dialysis Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 40.55% of the market in 2026, supported by established dialysis infrastructure, broad treatment access, mature reimbursement systems, and organized renal care networks.
- Asia Pacific is expected to grow at a 10.4% CAGR, driven by expanding dialysis capacity, improving access to renal care, earlier diagnosis, and wider adoption of both in-center and home-based treatments.
Segment Momentum
- Hemodialysis held a 78.57% share in 2026 due to its established clinical infrastructure, scalable in-center treatment capacity, and widespread reliance on supervised therapy delivery for long-term renal replacement care.
- Home-based care is the fastest-growing segment as patients and providers increasingly prefer flexible dialysis solutions that reduce dependence on facility-based scheduling and better support everyday lifestyle needs.
Market Expansion Drivers
- Rising chronic kidney disease prevalence driven by diabetes and hypertension increasing dialysis demand.
- Expansion of home-based dialysis and portable systems improving patient accessibility and treatment flexibility.
- Growing investments in renal care infrastructure across emerging economies expanding treatment access.
Leading Market Participants
- Leading players in the hemodialysis and peritoneal dialysis market include Fresenius Medical Care AG (Germany), Baxter International Inc. (United States), B. Braun SE (Germany), Nipro Corporation (Japan), Asahi Kasei Medical Co., Ltd. (Japan), Medtronic plc (Ireland), Becton, Dickinson and Company (United States), Nikkiso Co., Ltd. (Japan), DaVita Inc. (United States), Diaverum AB (Sweden).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 129.8 billion
- 2027 Estimated Market Size: USD 139.98 billion.
- Projected Market Size: USD 316.14 billion by 2036
- Growth Forecast: 9.31% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hemodialysis (Type) | Hospital-based (End-use) | Services (Product)
- Emerging Opportunity Segment: Hemodialysis (Type) | Home-based (End-use) | Consumables (Product)
Market Growth Drivers and Industry Trends
Rising chronic kidney disease prevalence driven by diabetes and hypertension increasing dialysis demand
The increasing burden of chronic kidney disease associated with diabetes and hypertension will propel hemodialysis and peritoneal dialysis market growth by expanding the population requiring renal replacement therapy. Persistent damage to kidney function can progress to advanced kidney disease in patients with poorly controlled metabolic and cardiovascular conditions, creating a sustained need for dialysis when kidney function becomes insufficient to maintain normal physiological balance. As healthcare systems improve screening and diagnosis of kidney disorders, more patients are being identified and referred for specialized renal care. The resulting need for regular blood-based or peritoneal treatment is increasing demand for dialysis equipment, consumables, treatment services, and supporting clinical infrastructure.
Expansion of home-based dialysis and portable systems improving patient accessibility and treatment flexibility
Growing adoption of home-based treatment models is changing the hemodialysis and peritoneal dialysis market by giving suitable patients greater flexibility in managing their therapy outside conventional dialysis centers. Home dialysis can reduce dependence on frequent facility visits and may allow treatment schedules to be adapted more closely to individual lifestyles and clinical requirements. Advances in compact equipment, remote monitoring, automated systems, and user-friendly treatment interfaces are supporting this transition by making home-based care easier to manage under appropriate clinical supervision. Portable and simplified dialysis technologies are particularly relevant for improving access among patients who face transportation challenges or live far from specialized renal treatment facilities.
Growing investments in renal care infrastructure across emerging economies expanding treatment access
Increasing healthcare investment in developing regions is expanding the hemodialysis and peritoneal dialysis market as governments and healthcare providers strengthen renal treatment capacity. The development of dialysis centers, hospital-based renal units, trained clinical workforces, and supply networks can improve the availability of essential services for patients who previously faced limited access to kidney replacement therapy. Infrastructure expansion is also supporting earlier integration of dialysis into organized chronic disease management programs, particularly as diabetes and hypertension become more prevalent. Improvements in healthcare financing, specialized facility development, and distribution of dialysis-related equipment are helping broaden the geographic reach of renal care.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising chronic kidney disease prevalence driven by diabetes and hypertension increasing dialysis demand | 2.00% | High | North America, Asia Pacific, Europe | High | Near Term |
| Expansion of home-based dialysis and portable systems improving patient accessibility and treatment flexibility | 1.60% | High | North America, Europe | High | Mid Term |
| Growing investments in renal care infrastructure across emerging economies expanding treatment access | 1.40% | High | Asia Pacific, Latin America, Middle East & Africa | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The hemodialysis and peritoneal dialysis market was led by North America, which accounted for a 40.55% share in 2026, reflecting advanced renal care infrastructure, broad access to dialysis services, and a substantial patient population requiring long-term kidney replacement therapy. Established networks of dialysis centers, hospitals, and home-based care programs support consistent treatment availability, while improvements in dialysis technologies are enhancing treatment efficiency and patient monitoring. Growing awareness of chronic kidney disease, increasing demand for personalized care pathways, and greater adoption of home dialysis are also influencing the regional market. Healthcare systems are increasingly emphasizing patient convenience and quality of life, encouraging the development of treatment models that allow eligible patients to receive dialysis outside traditional clinical environments.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, rising awareness of kidney disease, and increasing access to renal replacement therapies. Population aging, changing lifestyles, and the growing burden of chronic conditions are contributing to greater demand for dialysis services. Healthcare investment is improving the availability of specialized renal-care facilities, particularly in urban and developing healthcare markets, while technological improvements are supporting more efficient treatment delivery and monitoring. The gradual expansion of home-based dialysis, increasing healthcare coverage, and efforts to improve early diagnosis and management of kidney disease are further creating opportunities for both hemodialysis and peritoneal dialysis across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Quality Renal CareGermany emphasizes clinically reliable dialysis systems supported by standardized treatment protocols and advanced medical infrastructure. Healthcare providers in Germany continue investing in efficient dialysis technologies that enhance patient care and operational performance.
France 🇫🇷
Coordinated Renal ServicesFrance focuses on integrated dialysis care delivered through hospitals, specialized clinics, and community healthcare networks. Healthcare organizations in France continue adopting advanced equipment that supports consistent treatment quality and patient outcomes.
Italy 🇮🇹
Accessible Dialysis NetworksItaly strengthens dialysis care through broad treatment availability and modernization of renal care facilities. Healthcare providers in Italy increasingly evaluate technologies that simplify treatment delivery while supporting long-term patient management.
Japan 🇯🇵
Aging Patient SupportJapan prioritizes dialysis solutions designed for an aging population requiring consistent long-term renal care. Medical institutions in Japan increasingly adopt compact equipment and patient-focused technologies that improve treatment efficiency and comfort.
South Korea 🇰🇷
Digital Dialysis IntegrationSouth Korea incorporates digital monitoring and connected healthcare technologies into dialysis services for improved clinical oversight. Providers in South Korea are expanding patient-centered treatment models that support both hospital and home dialysis settings.
United States 🇺🇸
Home Dialysis ExpansionThe U.S. continues expanding home-based dialysis options alongside established center-based treatment services. Healthcare providers increasingly promote technologies that improve patient convenience, treatment flexibility, and long-term disease management.
Segment Leadership and Growth Trends
Hemodialysis and Peritoneal Dialysis Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Hemodialysis (Largest & Fastest-Growing Segment)
Hemodialysis dominated the hemodialysis and peritoneal dialysis market with a 78.57% share in 2026 and also represented the fastest-growing segment, supported by its established role in the management of advanced kidney failure and the extensive availability of dialysis infrastructure. The treatment provides effective removal of metabolic waste and excess fluid from the blood through an established clinical process, making it a widely adopted option for patients requiring ongoing renal replacement therapy. Its integration with specialized dialysis equipment, trained clinical personnel, and established treatment protocols continues to reinforce adoption. At the same time, improvements in dialysis technologies, treatment efficiency, and patient monitoring are supporting continued expansion of hemodialysis, strengthening its position as both the dominant and fastest-growing modality.
End-use Segment Analysis: Hospital-based (Largest Segment) vs Home-based (Fastest-Growing Segment)
The hospital-based segment held the largest share of the hemodialysis and peritoneal dialysis market at 73.68% in 2026, reflecting the continued importance of hospitals as comprehensive centers for dialysis delivery, patient monitoring, and management of complex renal conditions. Hospital settings provide access to specialized equipment, trained healthcare professionals, emergency support, and multidisciplinary care, which are particularly important for patients requiring intensive or closely supervised treatment. Established dialysis infrastructure and the concentration of renal care services within hospital environments further sustain demand for hospital-based treatment.
Home-based dialysis is gaining momentum as patients and healthcare systems increasingly seek more flexible approaches to long-term renal care. Home treatment can provide greater scheduling convenience, reduce dependence on frequent visits to clinical facilities, and allow therapy to be incorporated more closely into patients' daily routines. Advances in remote monitoring, connected medical technologies, patient training, and compact dialysis equipment are also improving the feasibility of home-based care, supporting its faster expansion as healthcare delivery becomes more decentralized and patient-centered.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Hemodialysis, Peritoneal Dialysis | Hemodialysis | Hemodialysis |
| End-use | Home-based, Hospital-based | Hospital-based | Home-based |
| Product | Device, Consumables, Services | Services | Consumables |
Competitive Landscape and Market Positioning
Key companies in the hemodialysis and peritoneal dialysis market:
1. Fresenius Medical Care AG (Germany)
2. Baxter International Inc. (United States)
3. B. Braun SE (Germany)
4. Nipro Corporation (Japan)
5. Asahi Kasei Medical Co. Ltd. (Japan)
6. Medtronic plc (Ireland)
7. Becton Dickinson and Company (United States)
8. Nikkiso Co. Ltd. (Japan)
9. DaVita Inc. (United States)
10. Diaverum AB (Sweden)
Growing prevalence of chronic kidney conditions is increasing demand for advanced renal replacement therapies. The hemodialysis and peritoneal dialysis market is witnessing improvements in treatment efficiency and patient monitoring systems. Enhanced device portability and automation are improving treatment accessibility. Continuous innovation in dialysis membranes is also supporting better clinical outcomes.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Fresenius Medical Care AG (Germany) | |||||||
| Baxter International Inc. (United States) | |||||||
| B. Braun SE (Germany) | |||||||
| Nipro Corporation (Japan) | |||||||
| Asahi Kasei Medical Co. Ltd. (Japan) | |||||||
| Medtronic plc (Ireland) | |||||||
| Becton Dickinson and Company (United States) | |||||||
| Nikkiso Co. Ltd. (Japan) | |||||||
| DaVita Inc. (United States) | |||||||
| Diaverum AB (Sweden). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Outset Medical | Jan-26 | Outset Medical secured FDA 510(k) clearance for its next-generation Tablo Hemodialysis System, marking a key regulatory milestone. The upgraded platform incorporates enhanced hardware, operating system improvements, and strengthened software aligned with updated cybersecurity standards introduced in 2025, supporting improved system performance, reliability, and clinical usability in dialysis delivery. |
| Mozarc Medical | Sep-25 | Mozarc Medical partnered with DK Medical Technology to strengthen PTA balloon technology capabilities for the U.S. arteriovenous access market. The collaboration focuses on improving vascular access solutions, a critical component of hemodialysis treatment infrastructure, supporting enhanced procedure reliability and access management in dialysis patient care pathways. |
| Fresenius Medical Care AG & Co. KGaA | Jun-25 | Fresenius Medical Care expanded U.S. commercialization of its 5008X CARE system following FDA 510(k) clearance, enabling broader deployment of high-volume hemodiafiltration therapy. The initiative advances adoption of next-generation dialysis modalities across U.S. clinical networks and strengthens positioning of hemodiafiltration as a potential emerging standard of care for chronic kidney disease management. |
| Nephrodite | Aug-24 | Nephrodite received FDA Breakthrough Device Designation for its implantable continuous dialysis platform, designed to operate externally to the body for continuous kidney function replacement. The designation accelerates regulatory engagement and development pathways for a novel dialysis modality aimed at transforming kidney replacement therapy beyond conventional hemodialysis and peritoneal dialysis approaches. |
| Dialyze Direct | Aug-23 | Dialyze Direct and Northeast Georgia Health Ventures established a strategic collaboration to deliver home dialysis services within skilled nursing facilities in Georgia. The initiative expands access to decentralized dialysis care in long-term care settings, supporting integration of chronic kidney treatment services into institutional care environments. |
| Fresenius Medical Care | Aug-23 | Fresenius Medical Care partnered with Sarah Bush Lincoln to launch a rural dialysis program in Illinois, enabling on-site dialysis services for underserved populations. The collaboration expands geographic access to kidney care services and strengthens Fresenius’ presence in rural healthcare delivery networks through localized treatment infrastructure deployment. |
| Rockwell Medical | Jul-23 | Rockwell Medical completed the acquisition of Evoqua Water Technologies’ hemodialysis concentrates business, strengthening its position in dialysis consumables. The transaction enhances Rockwell’s supply chain integration and expands its presence in critical dialysis treatment inputs, supporting greater control over manufacturing and distribution of concentrates used in hemodialysis treatment. |
| Nextkidney BV | Jan-22 | Nextkidney BV acquired Dialyss Pte Ltd, expanding its technological capabilities in home hemodialysis systems. The acquisition strengthens Nextkidney’s development pipeline and supports advancement of home-based renal care solutions, enhancing its positioning in the growing decentralized dialysis segment focused on patient-managed treatment environments. |
| DaVita | Mar-21 | DaVita entered an agreement with Fresenius Medical Care to expand utilization of NxStage home hemodialysis machines. The collaboration supports broader adoption of home-based dialysis therapies, reinforcing strategic efforts to shift treatment delivery away from in-center care toward more flexible, patient-centric home hemodialysis models across the dialysis ecosystem. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Hemodialysis and Peritoneal Dialysis Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Age Group | Pediatric, Adult, Geriatric |
| Provider Type | Hospitals & Clinics, Dialysis Centers, Home Care Providers |
| Reimbursement Type | Public Insurance, Private Insurance, Self-Pay |
Hemodialysis and Peritoneal Dialysis Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Home Dialysis Adoption Strategy |
|
| Dialysis Care Delivery Transformation |
|
| Patient Access Improvement Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of hemodialysis and peritoneal dialysis?
How much is the hemodialysis and peritoneal dialysis industry expected to grow by 2036?
How is the shift toward home-based dialysis influencing adoption across the hemodialysis and peritoneal dialysis market?
Why are renal care infrastructure investments becoming a strategic growth driver in the hemodialysis and peritoneal dialysis market?
Why does hemodialysis dominate the hemodialysis and peritoneal dialysis market?
Which end-use segment is growing fastest in the hemodialysis and peritoneal dialysis market?
Why does North America lead the hemodialysis and peritoneal dialysis market?
What is fueling market growth in Asia Pacific for dialysis therapies?
Which companies dominate the hemodialysis and peritoneal dialysis landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization